CAOHF yields 2000000.00% · PFE yields 6.20%● Live data
📍 CAOHF pulled ahead of the other in Year 1
Combined, CAOHF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CAOHF + PFE for your $10,000?
FDG Electric Vehicles Limited, an investment holding company, researches, designs, develops, manufactures, and sells electric vehicles in the People's Republic of China, the United States, Hong Kong, and internationally. It operates through Vehicle Design and Electric Vehicle Production, Battery Materials Production, and Direct Investments segments. The company also researches, develops, manufactures, and sells cathode materials for nickel-cobalt-manganese lithium-ion batteries and lithium ferrous phosphate batteries. In addition, it sells and distributes electric vehicles and battery products; human resources, administrative management, and consultancy services; and loan financing and securities trading services. Further, the company is involved in the asset investment activities; and purchase and sale of battery raw materials. The company was formerly known as Sinopoly Battery Limited and changed its name to FDG Electric Vehicles Limited in May 2014. FDG Electric Vehicles Limited is headquartered in Wanchai, Hong Kong.
Full CAOHF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.